Who
Jack Higgins
Chief Scientific Officer
Company insider
Files Form 4 as: Chief Scientific Officer, Immunome.
In numbers
- Trades disclosed
- 33
- Buys
- 0
- Sells
- 3
- Bought
- $0
- Sold
- $1.1M
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 1 Dec 2023
- Last trade
- 11 Sep 2026
- Last filed
- 15 Sep 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 11 Sep 2026filed 15 Sep 2026 | IMNM ImmunomeBiotechnology | SEC FORM 4 Code M | $24K18,000 at $1.35 | filing |
| 11 Sep 2026filed 15 Sep 2026 | IMNM ImmunomeBiotechnology | SEC FORM 4 Sold | $334K13,200 at $25.32 | filing |
| 11 Sep 2026filed 15 Sep 2026 | IMNM ImmunomeBiotechnology | SEC FORM 4 Code G | —8,800 at $0.00 | filing |
| 11 Sep 2026filed 15 Sep 2026 | IMNM Immunomeoption or derivative · Biotechnology | SEC FORM 4 Code M | —18,000 at $0.00 | filing |
| 11 Sep 2026filed 15 Sep 2026 | IMNM Immunomeoption or derivative · Biotechnology | SEC FORM 4 Code M | —18,000 at $0.00 | filing |
| 11 Sep 2026filed 15 Sep 2026 | IMNM ImmunomeBiotechnology | SEC FORM 4 Code M | $24K18,000 at $1.35 | filing |
| 11 Sep 2026filed 15 Sep 2026 | IMNM ImmunomeBiotechnology | SEC FORM 4 Sold | $334K13,200 at $25.32 | filing |
| 11 Sep 2026filed 15 Sep 2026 | IMNM ImmunomeBiotechnology | SEC FORM 4 Code G | —8,800 at $0.00 | filing |
| 23 Jul 2026filed 27 Jul 2026 | IMNM ImmunomeBiotechnology | SEC FORM 4 Code A | —38,250 at $0.00 | filing |
| 23 Jul 2026filed 27 Jul 2026 | IMNM Immunomeoption or derivative · Biotechnology | SEC FORM 4 Code A | —76,500 at $0.00 | filing |
| 23 Jul 2026filed 27 Jul 2026 | IMNM Immunomeoption or derivative · Biotechnology | SEC FORM 4 Code A | —76,500 at $0.00 | filing |
| 23 Jul 2026filed 27 Jul 2026 | IMNM ImmunomeBiotechnology | SEC FORM 4 Code A | —38,250 at $0.00 | filing |
| 2 Apr 2026filed 3 Apr 2026 | IMNM ImmunomeBiotechnology | SEC FORM 4 Sold | $204K9,438 at $21.64 | filing |
| 2 Apr 2026filed 3 Apr 2026 | IMNM ImmunomeBiotechnology | SEC FORM 4 Sold | $204K9,438 at $21.64 | filing |
| 30 Mar 2026filed 1 Apr 2026 | IMNM ImmunomeBiotechnology | SEC FORM 4 Code G | —6,291 at $0.00 | filing |
| 30 Mar 2026filed 1 Apr 2026 | IMNM ImmunomeBiotechnology | SEC FORM 4 Code G | —6,291 at $0.00 | filing |
| 19 Dec 2025filed 22 Dec 2025 | IMNM ImmunomeBiotechnology | SEC FORM 4 Code G | —1,000 at $0.00 | filing |
| 19 Dec 2025filed 22 Dec 2025 | IMNM ImmunomeBiotechnology | SEC FORM 4 Code G | —1,000 at $0.00 | filing |
| 19 Dec 2025filed 22 Dec 2025 | IMNM ImmunomeBiotechnology | SEC FORM 4 Code G | —1,000 at $0.00 | filing |
| 19 Dec 2025filed 22 Dec 2025 | IMNM ImmunomeBiotechnology | SEC FORM 4 Code G | —1,000 at $0.00 | filing |
News
Jack Higgins – The Bowdoin Orientbowdoinorient.com · 25 Sep 2026Arbutus Biopharma (NASDAQ:ABUS) vs. Immunome (NASDAQ:IMNM) Financial ComparisonIMNM · themarketsdaily.com · 12 Oct 2026
1 headline in the last 90 days name Jack Higgins; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.